Tag Archives: Gates Ventures

Revolutionizing Alzheimer's Research: Gates Ventures Backs a Million-Dollar AI Initiative

Supercharging Alzheimer’s Research: Gates Ventures Backs a Million-Dollar AI Initiative



Unlocking Innovation: The Alzheimer’s Insights AI Prize and Its Impact on Healthcare

There are currently more than 55 million people worldwide living with Alzheimer’s disease and related dementias. Recent breakthroughs in new treatments and diagnostics provide hope, but there is potential to accelerate the pace of discovery and development.

Last year, StartUp Health, in partnership with the Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator (DxA) and Gates Ventures, the private office of Bill Gates, launched the Alzheimer’s Moonshot. This initiative breaks down silos and fosters meaningful collaboration between mission-aligned founders, funders, and partners, accelerating progress in preventing, managing, and curing Alzheimer’s and related dementias through the support of entrepreneurial innovation.

Now, the Alzheimer’s Disease Data Initiative (AD Data Initiative) is backing visionary AI solutions to accelerate Alzheimer’s research with the launch of a new million-dollar prize competition. The goal is to leverage agentic AI – AI that can plan, reason, and act autonomously – to help drive breakthroughs in  Alzheimer’s disease and related dementias research.

Gregory Moore, MD, PhD, senior advisor to Gates Ventures and the Alzheimer’s Disease Data Initiative, sat down with us to share how you can join the competition to harness AI to radically accelerate Alzheimer’s disease research. The Alzheimer’s Insights AI Prize offers $1M to the winner for the agentic AI solution that can generate a powerful leap in the pace, scale, and reach of ADRD research.

Drawing from his unique background in both engineering and medicine, Dr. Moore discusses how AI could dramatically accelerate drug discovery and clinical trials by up to 50%. The initiative aims to break down traditional research barriers by harmonizing diverse data sets, from genomics to neuroimaging, making breakthroughs more accessible to the global scientific community.

The Alzheimer’s Insights AI Prize competition semi-finalist teams will be selected to present at a pitch event alongside the Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Diego this December, where innovators worldwide will present their ideas to a distinguished panel of judges from tech, academia, and venture capital. From there, up to three finalist teams will be invited to a final event at the AD/PD International Conference next March in Copenhagen, Denmark. With travel support available for participants, this initiative ensures global accessibility and collaboration.

Ready to learn how AI could revolutionize brain health research to potentially detect Alzheimer’s earlier, improve treatments, and work toward prevention and cures? Listen to this inspiring episode that bridges technology and medicine in the fight against dementia. Then visit Alzheimer’s Insights AI Prize to learn more and apply by September 12, 2025.

 


 

Do you want to participate in live conversations with industry luminaries? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Fireside Chats, Expert Office Hours, and Peer Circles are benefits of our Health Moonshot Community Membership. To get involved, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
» Learn more and apply today.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.


Inside the Alzheimer’s Moonshot Impact Board: Fostering Collaboration for Alzheimer's Innovation

Gates Ventures’ Aishu Sukumar Is Fostering Collaboration on StartUp Health’s Alzheimer’s Moonshot Impact Board



Breaking Down Silos for Alzheimer’s Innovation: A Conversation with Aishu Sukumar of Gates Ventures

This episode of StartUp Health NOW welcomes Aishu Sukumar of Gates Ventures in another in our series of conversations with our Alzheimer’s Moonshot Impact Board.

  • A champion for collaboration: Explore Sukumar’s vision for leveraging data and fostering collaboration among Alzheimer’s innovators.
  • From research scientist to moonshot leader: Discover Sukumar’s unique career path that bridges science, business, and healthcare, taking her from Harvard Medical School and Berkeley to working at startups and then to Gates Ventures.
  • The power of a Health Moonshot Community: Learn how this initiative is uniting innovators to accelerate progress against Alzheimer’s.

This episode is for you if:

  • You’re passionate about finding a cure for Alzheimer’s.
  • You believe in the power of collaboration in tackling complex challenges.
  • You’re curious about the journeys of inspiring healthcare leaders.

Want even more about Alzheimer’s disease innovation?

Join us as we explore how Aishu Sukumar’s diverse background is shaping the future of Alzheimer’s research as a member of our Alzheimer’s Moonshot Impact Board.


Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

FundersBecome a Health Moonshot Champion


Gates Ventures, Kristina Malzbender: Insider the Alzheimer's Moonshot Impact Board

Gates Ventures’ Kristina Malzbender Joins Alzheimer’s Moonshot Impact Board



Hope on the Horizon: A New Era of Alzheimer’s Innovation

This episode of StartUp Health NOW dives deep into the fight against Alzheimer’s disease in the second in our series of conversations with our Alzheimer’s Moonshot Impact Board. Join us as we chat with Kristina Malzbender, the Associate Director, Health & Life Sciences, at Gates Ventures. Hear from this key leader about the concrete realities behind the optimism in Alzheimer’s innovation.

  • A century of relentless pursuit: Learn how the tide is turning after decades of dedicated research.
  • Early detection, slowed progression, and even potential cures: Explore exciting advancements in Alzheimer’s treatment.
  • Gates Ventures and the Diagnostic Accelerator (DxA): Find out how Gates Ventures and the Alzheimer’s Drug Discovery Foundation (ADDF) are supporting companies and academic researchers developing novel biomarkers and diagnostics for Alzheimer’s.
  • Introducing StartUp Health’s Alzheimer’s Moonshot: Discover a powerful collaboration aimed at accelerating progress

This episode is for you if:

  • You’re passionate about Alzheimer’s disease.
  • You’re curious about the latest advancements in dementia research.
  • You want to learn how you can contribute to the fight against Alzheimer’s.

Want even more about Alzheimer’s disease innovation?

Join us as we ignite hope for the future of Alzheimer’s innovation!


 

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

FundersBecome a Health Moonshot Champion